Propanc Biopharma (PPCB) Short term Debt (2011 - 2025)
Propanc Biopharma (PPCB) posted quarterly Short term Debt of $55000.0 for Q4 2025, down 86.58% year-over-year from $409799.0 in Q4 2024, and down 48.58% quarter-over-quarter from $106968.0 in Q3 2025.
Propanc Biopharma (PPCB) Short term Debt (2011 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Short term Debt for 15 consecutive years, with $55000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Short term Debt fell 86.58% year-over-year to $55000.0; the TTM figure through Dec 2025 stood at $55000.0 (down 86.58% YoY), while the FY2025 annual figure was $537921.0, up 34.71% from the prior year.
- Short term Debt slipped to $55000.0 in Q4 2025 per PPCB's latest filing, from $106968.0 in the prior quarter.
- Across five years, Short term Debt topped out at $1.1 million in Q1 2022 and bottomed at $32076.0 in Q3 2021.
- Historically, Short term Debt has averaged $471128.8 across 5 years, with a median of $404562.0 in 2024.
- Annual changes were most pronounced in 2021 — Short term Debt tumbled 96.88% — and 2022, when it soared 2748.36%.
- Propanc Biopharma's Short term Debt stood at $972670.0 in 2021, then slumped by 93.29% to $65280.0 in 2022, then surged by 953.39% to $687650.0 in 2023, then tumbled by 40.41% to $409799.0 in 2024, then plunged by 86.58% to $55000.0 in 2025.
- Business Quant data shows PPCB's Short term Debt at $55000.0 in Q4 2025, $106968.0 in Q3 2025, and $537921.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,000.00 |
| Sep 30, 2025 | 106,968.00 |
| Jun 30, 2025 | 537,921.00 |
| Mar 31, 2025 | 438,578.00 |
| Dec 31, 2024 | 409,799.00 |
| Sep 30, 2024 | 381,789.00 |
| Jun 30, 2024 | 399,325.00 |
| Mar 31, 2024 | 582,951.00 |
| Dec 31, 2023 | 687,650.00 |
| Sep 30, 2023 | 397,443.00 |
| Jun 30, 2023 | 390,539.00 |
| Mar 31, 2023 | 65,280.00 |
| Dec 31, 2022 | 65,280.00 |
| Sep 30, 2022 | 913,641.00 |
| Jun 30, 2022 | 926,438.00 |
| Mar 31, 2022 | 1.08 Mn |
| Dec 31, 2021 | 972,670.00 |
| Sep 30, 2021 | 32,076.00 |
| Jun 30, 2021 | 33,347.00 |
| Mar 31, 2021 | 950,180.00 |